Publications 2021


“Abnormal Motor Surround Inhibition Associated with Cortical and Deep Grey Matter Involvement in Multiple Sclerosis. ” D Belvisi, C Giannì, M Tartagli, N Petsas, V Baione, SG Crisafulli, P Pantano, A Berardelli, A Conte. Clinical Neurophysiology 132 doi: (2021).

“Linear Brain Atrophy Measures in Multiple Sclerosis and Clinically Isolated Syndromes: a 30-year Follow-Up.” L Haider, K Chung, G Birch, A Eshaghi, S Mangesius, F Prados, C Tur, O Ciccarelli, F Barkhof, D Chard. Journal of Neurology, Neurosurgery & Psychiatry doi: 10.1136/jnnp-2020-325421 (2021).

“Normalization of Spinal Cord Total Cross-Sectional and Gray Matter Areas as Quantified With Radially Sampled Averaged Magnetization Inversion Recovery Acquisitions.” EM Kesenheimer, MJ Wendebourg, M Weigel, C Weidensteiner, T Haas, L Richter, L Sander, A Horvath, M Barakovic, P Cattin, C Granziera, O Bieri, R Schlaeger. Frontiers in Neurology doi: (2021).

“Individual Markers of Cerebral Small Vessel Disease and Domain‐Specific Quality of Life Deficits.” J Fernando, RB Brown, H Edwards, M Egle, HS Markus, J Tay. Brain and Behavior doi: (2021).

“Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study.” P Preziosa, L Storelli, A Meani, L Moiola, M Rodegher, M Filippi, MA Rocca. Neurotherapeutics doi: (2021).

“Differentiating Axonal Loss and Demyelination in Chronic MS Lesions: A Novel Approach using Single Streamline Diffusivity Analysis.” S Klistorner, MH Barnett, J Wasserthal, C Yiannikas, J Barton, J Parratt, Y You, SL Graham, A Klistorner. PLoS One (2021).